Novel serum biomarkers for erythropoietin use in humans: a proteomic approach

Erythropoietin (Epo) is produced primarily in the kidneys upon low blood oxygen availability and stimulates erythropoiesis in the bone marrow. Recombinant human Epo (rHuEpo), a drug developed to increase arterial oxygen content in patients, is also illicitly used by athletes to improve their enduran...

Full description

Saved in:
Bibliographic Details
Main Authors: Christensen, Britt, Sackmann-Sala, Lucila, Cruz-Topete, Diana, Jørgensen, Jens Otto L., Jessen, Niels, Lundby, Carsten, Kopchick, John J.
Format: Artigo
Language:Inglês
Published: American Physiological Society 2011
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785117/
https://ncbi.nlm.nih.gov/pubmed/20966191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/japplphysiol.00665.2010
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items